Lipodystrophy Increases the Risk of CKD Development in HIV-Positive Patients in Switzerland: The LIPOKID Study

INTRODUCTION: Antiretroviral therapy has improved the life expectancy of patients living with HIV. However, lipodystrophy syndrome (LD) remains prevalent, affecting mostly patients treated with first-generation antiretroviral drugs. This syndrome is characterized by changes in body fat distribution...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouatou, Yassine, Gayet Ageron, Angele, Bernasconi, Enos, Battegay, Manuel, Hoffmann, Matthias, Staehelin, Cornelia, Merz, Laurent, Kovari, Helen, Fux, Christoph, de Seigneux, Sophie, Calmy, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127405/
https://www.ncbi.nlm.nih.gov/pubmed/30197975
http://dx.doi.org/10.1016/j.ekir.2018.04.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127405/
https://www.ncbi.nlm.nih.gov/pubmed/30197975
http://dx.doi.org/10.1016/j.ekir.2018.04.014

Ejemplares similares